DHX9 and neoplasm: Collectively, TRIM25 binds with DHX9 and DDX5 to participate in RNA processing to downregulate TCA enzyme expression, thereby remodeling the TCA cycle and glycolytic flux is increased to promote tumor proliferation (Figure 5E).